Hailir Pharmaceutical Group's 2 billion new technical project of difenoconazole, propiconazole, diafenthiuron, and chlorfenapyr will be officially completed and put into operation in 2021

On February 7, 2021, Hailir Pharmaceutical Group Co., Ltd. subsidiary Qingdao Hengning Biotechnology Co., Ltd. subsidiary Qingdao Hengning Biotechnology Co., Ltd.'s second phase of the original drug production project was officially registered in Qingdao Pingdu City Bureau of Industry and Information Technology, marking Hailir The construction progress of the Hengning Biological Project of the Pharmaceutical Group has taken a big step forward.


Previously, Hailir Pharmaceutical Group Hengning Bio-Phase I diafenthiuron, chlorfenapyr, difenoconazole, propiconazole and other technical projects have been officially obtained by the Qingdao Municipal Ecological Environment Bureau on December 28, 2020. The approval marks the official start of the construction of the Hailir Pharmaceutical Group's annual production of 40,000 tons of agricultural chemical raw materials and intermediates.


April 2020, Hailir Pharmaceutical Group's 40,000-ton agricultural chemical raw materials and intermediates project was officially approved by the Qingdao Development and Reform Commission. The total investment of the project is 2 billion yuan. The project address is located in Qingdao Pingdu Xinhe Ecological Chemical Technology The industrial base covers a total area of 429 acres, with a planned construction area of 1,51065 square meters, a newly built construction area of 69,454 square meters, and 1,320 sets of equipment purchased in the first phase. It mainly produces 2,000 tons of dichloroacetophenone and 6,000 tons of triazole. 2200 bromopyrrole, 2200 tons of diisopropylthiourea, 800 tons of dichlorotrifluoromethylaniline, 1438 tons of diisopropylaniline, 1810 tons of diisopropylphenyl isocyanate, 2500 tons of 3-bromo-1- (3-Chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid, 1500 tons of ethyl methylpyrrole formate, 1200 tons of oxadiazolone, 3325 tons of phenyl ether ketone and other technical and intermediate products.

The second phase of Hengning Biological Project has passed the project registration and is under planning and construction.

Qingdao Hengning Biological Technology Co., Ltd. is constructed in accordance with the management philosophy of multinational companies and international design standards, with the design principles of advanced equipment, continuous process, automatic operation, clean workshop, and green factory to lead the industry development in the next 10 years For the purpose of construction, with the development of humanistic Hengning, intelligent Hengning, and green Hengning as the development blueprint, it will lay a solid foundation for the sustainable development of the future pesticide technical and pharmaceutical intermediates of Hailir Pharmaceutical Group.